Targeted diagnosis of bladder and ureteral carcinoma using radiolabelled BDI-1

Urological Research

Volumn 26, Issue 5, 1998, Pages 343-348

  Zhang, C L ^a   Yu, L Z ^a   Gu, F L ^a   Buka, S D ^a   Zu, S L ^a   Xie, S S ^a   Pan, Z Y ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Bladder cancer; Monoclonal antibody; Radioimmunoimaging; Technetium 99 m Iodine 131

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BDI 1; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; URETER CARCINOMA; UROGENITAL SCINTISCANNING;

AGED; ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CROSS REACTIONS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TECHNETIUM; TUMOR MARKERS, BIOLOGICAL; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0031793130     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050067     Document Type: Article

References (18)

1. 111indium-labelled monoclonal anti-CEA antibody BW 431-26. Br J Cancer (Suppl x) 62:81
2. Buraggi CL (1985) Radioimmunodetection of cancer. J Nucl Med Allied Sci 29:261
3. Chinese Pharmacopeia (II) (1990). Chemical Industrial Inc. and Popular Hygienic Inc., Beijing p 106
4. Dianyuan Xu, Shuguang Qiao (1981) Diagnosis and treatment of malignancy. Shan Xi People's Inc., Shan Xi, p 159
5. Goldenberg DM, Deland F, Kim E (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancer by external photoscanning. N Engl J Med 298:1384
6. Goldenberg DM (1987) Current status of cancer imaging with radiolabelled antibodies. J Cancer Res Clin Oncol 113:203
7. Green AJ, Begent RHJ, Keep PA, Bagshawe KD (1984) Analysis of radioimmunodetection of tumors by the subtraction techniques. J Nucl Med 25.96
8. Halpern SE, Dillman RO (1987) Problems associated with radioimmunodetection and possibilities for future solutions. J Biol Response Mod 6:235
9. Rodwell JD (1990) Antibody mediated delivery system. Marcel Dekker, New York, p 245
10. 99Tc MAK BW 431 26). Wien Klin Wochenschr 101:621
11. Kunkler RB, Bishop MC, Green DJ, Pimm MV, Price MR, Frier M (1995) Targeting of bladder cancer with monoclonal antibody NCRC 48: a possible approach for intravesical therapy. Br J Urol 76:81
12. Larson SM (1990) Clinical radioimmunodetdction 1978-1988: overview and suggestions for standardization of clinical trials. Cancer Res 50(Suppl.):892S
13. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA (1984) Determination of the immunoreactive fraction of radiolabelled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 72:77
14. Ma AH, Xie SS, Long ZZ, Yu LZ, Gu FL (1990) The production and characterization of a monoclonal antibody against human bladder carcinoma Chin J Urol 11:195
15. Murray JL, Unger MW (1988) Radioimmunodetection of cancer with monoclonal antibodies: current status, problems and future directions. CRC Crit Rev Oncol Hematol 8:227
16. Rockoff SD, Goodenough DJ, Mclntire KR (1980) Theoretical limitations in the immunodiagnostic imaging of cancer with computed tomography and nuclear scanning. Cancer Res 40:3054
17. 99mTc-anti-BIU-87 McAb and tumor radioimmunoimaging. Chin J Urol 14:406
18. Zorzos J, Skarlos DV, Pozatzidou P, Zizi A, Bakiras A, Koritsadis S, Pectasidis D, Koutsioumba P, Epenetos AA, Likourinas M (1994) Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder. Urol Res 22:323